TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19 <strong> </strong>
Xinchen Wang(Columbia University Irving Medical Center), David B. Goldstein(Duke University), Ryan S. Dhindsa(Baylor College of Medicine), Anthony W. Zoghbi(Baylor College of Medicine), Nicholas Nickols(University of California, Los Angeles), Joseph Hostyk(A&G Pharmaceutical (United States)), Gundula Povysil(Bridgepoint (United States)), Joshua Motelow(Morgan Stanley Children's Hospital), Matthew B. Rettig(University of Southern California)
Cited by 15
Related Papers
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies
|Nature Communications|2018|517
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
Rare-variant collapsing analyses for complex traits: guidelines and applications
|Nature Reviews Genetics|2019|241